The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro

Research output: Contribution to journal › Article › peer-review

112 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{b74f13a185eb4102ab138b87e7cde2d9,

title = "The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro",

author = "Stephen Blake and Timothy Hughes and Graham Mayrhofer and Alan Lyons",

year = "2008",

language = "English",

volume = "127",

pages = "330--339",

journal = "Clinical Immunology",

issn = "1521-6616",

publisher = "Academic Press Inc.",

number = "3",

}